Related Experiment Video

Updated: Jun 7, 2026

Antigen-Capture Enzyme-Linked Immunosorbent Assay for Specific Detection of Mycoplasma pneumoniae
06:04

Antigen-Capture Enzyme-Linked Immunosorbent Assay for Specific Detection of Mycoplasma pneumoniae

Published on: February 24, 2023

[Asthma and Mycoplasma pneumoniae]

E Blanchard1, C Raherison

  • 1Service des maladies respiratoires, CHU de Bordeaux, université Bordeaux-2 Victor-Segalen, Bordeaux, France. elodieblfr@yahoo.fr

Revue Des Maladies Respiratoires
|October 23, 2010
PubMed
Abstract

Insights

Mycoplasma pneumoniae infection may contribute to asthma development and exacerbation. Eradicating this pathogen with macrolide antibiotics could potentially improve asthma symptoms and management.

Area of Science:

  • Respiratory Medicine
  • Microbiology
  • Immunology

Context:

  • Mycoplasma pneumoniae is increasingly implicated in asthma pathogenesis.
  • Its precise role in asthma development, exacerbation, and persistence remains unclear.
  • Infection may precipitate asthma in predisposed individuals and enhance chronic airway inflammation.

Purpose:

  • To review the current understanding of Mycoplasma pneumoniae's role in asthma.
  • To explore the potential impact of M. pneumoniae eradication on asthma management.
  • To discuss the implications of macrolide antibiotics in treating asthma.

Summary:

  • Mycoplasma pneumoniae infection is linked to asthma development and exacerbation, potentially by inducing bronchial hyperresponsiveness and enhancing airway inflammation.
  • Detecting M. pneumoniae in asthma patients can be challenging, complicating research efforts.
  • Macrolide antibiotics, possessing both antimicrobial and anti-inflammatory properties, may offer a therapeutic option, particularly for steroid-dependent asthma.

Impact:

  • Understanding M. pneumoniae's role can lead to targeted therapies for asthma.
  • Eradication of M. pneumoniae might improve asthma control and reduce symptom severity.
  • Further research is needed to establish the definitive role of macrolides in asthma management.

Related Concept Videos

Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Asthma I: Introduction01:28

Asthma I: Introduction

Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Asthma III: Clinical Manifestations01:13

Asthma III: Clinical Manifestations

Asthma presents with a characteristic pattern of episodic respiratory symptoms that reflect underlying airway inflammation, bronchoconstriction, and mucus hypersecretion. Although severity varies among individuals, certain clinical manifestations are considered hallmarks of the disorder and often guide diagnosis and assessment.Respiratory SymptomsA persistent cough is one of the most common early features of asthma. It is frequently dry and tends to worsen at night or in the early morning,...
Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...